Guangdong Baolight Medical Technology Co., Ltd. announced the continued suspension of trading for its shares and convertible bonds due to the planning of a change in controlling shareholder. The suspension, initially for no more than two trading days from August 3, 2026, is extended for no more than three additional trading days from August 5, 2026, to protect investor interests.
Summary generated by AI · Always verify with source document
Securities Code: 300246
Bond Code: 123065
Securities Abbreviation: Baolight
Bond Abbreviation: Baolight Convertible Bond
Announcement No.: 2026-055
Guangdong Baolight Medical Technology Co., Ltd.
Announcement on the Planning of Company Control Change and Continued Suspension of Trading
The company and all members of its board of directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.